Back to search results

Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Small Cell Neuroendocrine Carcinoma of Bladder · Bladder Cancer · Urothelial Carcinoma Bladder

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Johns Hopkins University: Sibley Memorial Hospital, Washington D.C., District of Columbia, United States

    Contact: Study coordinator (Carol Goldener, RN) · cgolden9@jhmi.edu · 202-660-5629
    Contact: Principal Investigator (Jean Hoffman-Censits, MD)

  • Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States

    Contact: Study coordinator (Deborah Schwartz, RN) · BladderCancerClinicalTrials@live.johnshopkins.edu · 410-502-4523
    Contact: Principal Investigator (Jean Hoffman-Censtis, MD)
Study leads

  • Jean Hoffman-Censits, MD

    Principal Investigator

    Johns Hopkins University

View source on ClinicalTrials.gov(opens in a new tab)